IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. (12th June 2019) - Rusconi, C.; Tucker, D.; Bernard, S.; Muzi, C.; Crucitti, L.; Stefani, P.; Cox, M.; Gini, G.; Re, A.; Sciarra, R.; Liberati, A.; Morello, L.; et al.